• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制药行业透明医学信息合作(phactMI™)基准研究:支持部门战略制定的医学信息服务组织结构和资源配置的结果。

Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Results of Organizational Structure and Resourcing of Medical Information Services in Support of Building Departmental Strategies.

机构信息

Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA.

Eli Lilly, Indianapolis, IN, USA.

出版信息

Ther Innov Regul Sci. 2020 Nov;54(6):1269-1274. doi: 10.1007/s43441-020-00143-1. Epub 2020 Mar 14.

DOI:10.1007/s43441-020-00143-1
PMID:33123969
Abstract

BACKGROUND

An opportunity exists to leverage the collective insights and experiences of phactMI™ member companies on current medical information (MI) services across the pharmaceutical industry. The collective insights provide considerations for refined MI strategies and enhanced MI services. The trend of organizational structure and challenge of resourcing for MI services are key areas to support efficiency and bring value to the overall organization.

METHODS

Between December 2017 and February 2018, all 27 phactMI™ member companies were electronically sent a 300-question survey to support the development of MI services across the pharmaceutical industry. The survey had 9 key areas of focus, including organizational structure and resourcing.

RESULTS

All 27 companies responded to the survey. Although the 27 companies survey differed in structure and size, the MI responsibilities performed both by in-house and outsourced groups were similar with each organization. Half of the groups outsourced various responsibilities which supported the non-product roles, such as quality assurance, compliance reporting, vendor operations management, reporting/analytics, technology and digital support, content-related process work, presentation specialists, and payer and health system support. Despite the ever-changing nature of the pharmaceutical industry, most responsibilities and outsourced work by MI groups remain the same over time.

CONCLUSION

These findings provide MI teams various options for organizational structuring and resource strategies for MI services. These results highlight the services and focus areas that MI departments can explore and support the development of additional MI services across the pharmaceutical industry.

摘要

背景

有机会利用 phactMI™ 成员公司在整个制药行业当前医疗信息 (MI) 服务方面的集体洞察力和经验。这些集体见解为完善 MI 策略和增强 MI 服务提供了考虑因素。MI 服务的组织结构趋势和资源配置挑战是支持效率并为整个组织带来价值的关键领域。

方法

在 2017 年 12 月至 2018 年 2 月期间,向所有 27 家 phactMI™ 成员公司发送了一份 300 个问题的电子调查,以支持整个制药行业的 MI 服务发展。该调查有 9 个重点关注领域,包括组织结构和资源配置。

结果

所有 27 家公司都对调查做出了回应。尽管 27 家公司的调查结构和规模不同,但内部和外包团体执行的 MI 职责在每个组织中都相似。一半的团体将各种职责外包出去,以支持非产品角色,如质量保证、合规报告、供应商运营管理、报告/分析、技术和数字支持、内容相关流程工作、演示专家以及支付方和医疗系统支持。尽管制药行业的性质不断变化,但 MI 团队的大多数职责和外包工作随着时间的推移保持不变。

结论

这些发现为 MI 团队提供了各种组织结构和 MI 服务资源策略的选择。这些结果突出了 MI 部门可以探索和支持整个制药行业更多 MI 服务发展的服务和重点领域。

相似文献

1
Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Results of Organizational Structure and Resourcing of Medical Information Services in Support of Building Departmental Strategies.制药行业透明医学信息合作(phactMI™)基准研究:支持部门战略制定的医学信息服务组织结构和资源配置的结果。
Ther Innov Regul Sci. 2020 Nov;54(6):1269-1274. doi: 10.1007/s43441-020-00143-1. Epub 2020 Mar 14.
2
Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Trends, Drivers, and Value of Product Support Activities, Key Performance Indicators, and Other Medical Information Services: Insights from a Survey of 27 US Pharmaceutical Medical Information Departments.制药行业透明医疗信息合作(phactMI™)基准研究:产品支持活动、关键绩效指标和其他医疗信息服务的趋势、驱动因素和价值:来自对 27 家美国制药医疗信息部门调查的见解。
Ther Innov Regul Sci. 2020 Nov;54(6):1275-1281. doi: 10.1007/s43441-020-00162-y. Epub 2020 May 23.
3
phactMI Benchmarking Survey on Content Development and Inquiry Management.phactMI 内容开发和查询管理基准测试调查。
Ther Innov Regul Sci. 2020 Nov;54(6):1263-1268. doi: 10.1007/s43441-020-00137-z. Epub 2020 Mar 4.
4
Where are We Now in Providing Medical Information in the Digital Space? A Benchmark Survey of PhactMI™ Member Companies.我们现在在数字空间提供医疗信息方面处于什么位置?PhactMI™成员公司的基准调查。
Ther Innov Regul Sci. 2020 Nov;54(6):1282-1290. doi: 10.1007/s43441-020-00222-3. Epub 2020 Sep 25.
5
An Update from the Benchmark Survey of phactMI™ Member Companies on Providing Medical Information in the Digital Space.phactMI™ 会员公司在数字空间提供医学信息的基准调查更新。
Ther Innov Regul Sci. 2024 Jan;58(1):200-213. doi: 10.1007/s43441-023-00587-1. Epub 2023 Nov 10.
6
phactMI™ Benchmarking Survey: Analysis of 27 Medical Information Departments Responses to Inquiries from Health Care Decision Makers.phactMI™ 基准调查:对 27 个医疗信息部门回应医疗保健决策者查询的分析。
Ther Innov Regul Sci. 2020 Nov;54(6):1291-1295. doi: 10.1007/s43441-020-00148-w. Epub 2020 Apr 8.
7
Pharma Collaboration for Transparent Medical Information (phactMI) Benchmark Study: Trends, Drivers, Success Factors, and Value of Globalization in Medical Information.透明医疗信息制药合作组织(phactMI)基准研究:医疗信息全球化的趋势、驱动因素、成功因素及价值
Ther Innov Regul Sci. 2019 May;53(3):332-339. doi: 10.1177/2168479018779920. Epub 2018 Jun 19.
8
Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).基于对德国创新型制药企业协会(vfa)成员进行的一项调查,CRO监管的当前实践与展望
Ger Med Sci. 2017 Jan 26;15:Doc02. doi: 10.3205/000243. eCollection 2017.
9
How do the top 12 pharmaceutical companies operate safety pharmacology?排名前12的制药公司如何开展安全药理学研究?
J Pharmacol Toxicol Methods. 2012 Sep;66(2):66-70. doi: 10.1016/j.vascn.2012.03.004. Epub 2012 Apr 1.
10
The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position Paper.建立在线获取医疗信息服务的欧洲治理模式的迫切需求:立场文件。
Pharmaceut Med. 2021 May;35(3):147-155. doi: 10.1007/s40290-021-00390-z. Epub 2021 Jul 14.